New Tokyo-based company Asajes Ventures is aiming to create a new financial risk-sharing product development model for companies, mostly from the West, looking to bring their late pipeline or commercialized molecules to Asia, specifically Japan and China.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?